Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06748755

A Comparative Analysis of Ultrasound's Accuracy in Diagnosing HC Using Histopathology as Gold Standard

A Comparative Analysis of Ultrasound's Accuracy in Diagnosing Hepatocellular Carcinoma Using Histopathology as Gold Standard

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Superior University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The study aims to evaluate the accuracy of ultrasound in diagnosing hepatocellular carcinoma (HCC), using histopathology as the gold standard. It addresses HCC's high global incidence and the utility of ultrasound as a non-invasive, cost-effective screening tool. Despite ultrasound's accessibility, its diagnostic limitations necessitate further investigation to improve clinical outcomes.

Conditions

Interventions

TypeNameDescription
RADIATIONGroup 1To determine the sensitivity of ultrasound in detecting HCC

Timeline

Start date
2024-03-01
Primary completion
2024-09-01
Completion
2025-02-20
First posted
2024-12-27
Last updated
2024-12-27

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06748755. Inclusion in this directory is not an endorsement.